posted on
Sep 01, 2020 06:02AM

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Message: Form 3
Who owns the 630,000 Class A shares of "PTSC Sub One"?
Be aware that each Class A share converts in 5,097 and .053 shares (!) - and NOT 5,097,053!
Nicole Steinmetz = 217,000 (she: 161,000 - her husband: 56,000) = normal PTSC shares:
1 billion 106 million 164,010
Steven King = 161,000 = normal PTSC shares:
820 million 702,330
Paul Lytle = 161,000 = normal PTSC shares:
820 million 702,330
Robert Garnick = 35,000 = normal PTSC shares:
178 million 413,550
2,925982,220 shares in total:
2 billion 925 million 982,220
But who owns the Class B shares of "PTSC Sub One"?
In the fillings it's written:
"As the sole holder of the Series B Preferred Stock the INVESTOR shall receive certain registration rights and information rights, to which the Company has agreed under the SPA."
and the INVESTOR is:
INVESTOR: CASE WESTERN RESERVE UNIVERSITY |
IN WITNESS WHEREOF, the parties have executed this INVESTORS’ RIGHTS AGREEMENT as of the date first written above.
PATRIOT SCIENTIFIC CORPORATION | ||
By: | ||
Name: |
Carlton Johnson |
|
Title: | Interim CEO | |
INVESTOR: CASE WESTERN RESERVE UNIVERSITY |
||
By: | ||
Name: | Michael Haag | |
Title: |
Executive Director, Technology Management |
|
|
||
By: | ||
Name: | Michael Lee | |
Title: | Treasurer |
1 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply